GVA launches new Life Sciences Group.GVA GVA general visceral afferent system of nerves. has launched a Life Sciences Practice Group to serve the rapidly growing biotechnology industry. GVA partners around the world have been providing specialized services to a growing client base representing the life sciences, biotech and pharmaceutical sectors for nearly ten years, during which time the industry has more tripled in size. Biotechnology revenues increased from $8 billion in 1992 to more than $27 billion in 2001 according to according to prep. 1. As stated or indicated by; on the authority of: according to historians. 2. In keeping with: according to instructions. 3. the Biotechnology Industry Organization Biotechnology Industry Organization or BIO was founded 1993 in Washington, DC. James C. Greenwood is BIO's current President. External links
The following is a list of the top 100 biotechnology companies ranked by revenue. The first nine companies qualify for the list of the top 50 pharmaceutical companies. , academic institutions, state biotechnology enters and related organizations. Kathleen C. Doyle, principal of GVA Thompson Doyle Hennessey & Everest in Boston, heads up GVA's new task force. "With research and laboratory vacancy rates dramatically below that of the overall marketplace, life science companies face extraordinary challenges," Doyle said. GVA's Life Sciences practice includes partners from America's top biotech centers, including Boston, San Francisco San Francisco (săn frănsĭs`kō), city (1990 pop. 723,959), coextensive with San Francisco co., W Calif., on the tip of a peninsula between the Pacific Ocean and San Francisco Bay, which are connected by the strait known as the Golden , New York/New Jersey, Philadelphia, Raleigh-Durham, San Diego, Seattle, Washington D.C./Baltimore and Los Angeles. The group also includes representatives from leading European biotech markets, including London, Munich and Dublin. |
|
||||||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion